טוען...
Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability
Nomegestrol acetate (NOMAC) 2.5 mg with 17-beta estradiol (E2) 1.5 mg is a new combined oral contraceptive (COC) formulation and is the first monophasic E2 pill to be marketed, having been licensed for use in Europe in 2011. It is available to be taken daily in a regimen of 24 active pills followed...
שמור ב:
| הוצא לאור ב: | Open Access J Contracept |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5683186/ https://ncbi.nlm.nih.gov/pubmed/29386925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OAJC.S61942 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|